Targeting PARP1 in XRCC1 Deficient Sporadic Invasive Breast Cancer or Pre-Invasive Ductal Carcinoma in Situ Induces Synthetic Lethality and Chemoprevention
Cancer Research - United States
doi 10.1158/0008-5472.can-18-0633
Full Text
Open PDFAbstract
Available in full text
Date
October 8, 2018
Authors
Publisher
American Association for Cancer Research (AACR)